Stocks
Adaptive Biotechnologies (ADPT) Debt/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 1.25 | 2.23 | 1.31 | 1.03 | -1.80 | 0.46 | ||
| Changes by years, y/y, % | -69% | +78% | -41% | -21% | -274% | |||
Adaptive Biotechnologies. Debt/EBITDA
Adaptive Biotechnologies. Debt/EBITDA, changes, %
Adaptive Biotechnologies (ADPT) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 0.89 | 1.15 | 2.29 | -1.44 | 0.46 | 0.46 | ||
| Changes by years, y/y, % | -25% | +5% | +147% | -239% | -48% | |||
| Changes by quarters, q/q, % | -13% | +29% | +99% | -163% | -132% | |||
